Advanced Drug Delivery Reviews, volume 184, pages 114194

Artificial intelligence to bring nanomedicine to life

Publication typeJournal Article
Publication date2022-05-01
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor16.1
ISSN0169409X, 18728294
Pharmaceutical Science
Abstract
The technology of drug delivery systems (DDSs) has demonstrated an outstanding performance and effectiveness in production of pharmaceuticals, as it is proved by many FDA-approved nanomedicines that have an enhanced selectivity, manageable drug release kinetics and synergistic therapeutic actions. Nonetheless, to date, the rational design and high-throughput development of nanomaterial-based DDSs for specific purposes is far from a routine practice and is still in its infancy, mainly due to the limitations in scientists' capabilities to effectively acquire, analyze, manage, and comprehend complex and ever-growing sets of experimental data, which is vital to develop DDSs with a set of desired functionalities. At the same time, this task is feasible for the data-driven approaches, high throughput experimentation techniques, process automatization, artificial intelligence (AI) technology, and machine learning (ML) approaches, which is referred to as The Fourth Paradigm of scientific research. Therefore, an integration of these approaches with nanomedicine and nanotechnology can potentially accelerate the rational design and high-throughput development of highly efficient nanoformulated drugs and smart materials with pre-defined functionalities. In this Review, we survey the important results and milestones achieved to date in the application of data science, high throughput, as well as automatization approaches, combined with AI and ML to design and optimize DDSs and related nanomaterials. This manuscript mission is not only to reflect the state-of-art in data-driven nanomedicine, but also show how recent findings in the related fields can transform the nanomedicine's image. We discuss how all these results can be used to boost nanomedicine translation to the clinic, as well as highlight the future directions for the development, data-driven, high throughput experimentation-, and AI-assisted design, as well as the production of nanoformulated drugs and smart materials with pre-defined properties and behavior. This Review will be of high interest to the chemists involved in materials science, nanotechnology, and DDSs development for biomedical applications, although the general nature of the presented approaches enables knowledge translation to many other fields of science.

Citations by journals

1
2
3
4
5
Advanced Drug Delivery Reviews
Advanced Drug Delivery Reviews, 5, 12.82%
Advanced Drug Delivery Reviews
5 publications, 12.82%
Advanced Materials
Advanced Materials, 3, 7.69%
Advanced Materials
3 publications, 7.69%
Advanced healthcare materials
Advanced healthcare materials, 2, 5.13%
Advanced healthcare materials
2 publications, 5.13%
Small
Small, 1, 2.56%
Small
1 publication, 2.56%
Molecules
Molecules, 1, 2.56%
Molecules
1 publication, 2.56%
Future Internet
Future Internet, 1, 2.56%
Future Internet
1 publication, 2.56%
Nature Materials
Nature Materials, 1, 2.56%
Nature Materials
1 publication, 2.56%
Seminars in Cancer Biology
Seminars in Cancer Biology, 1, 2.56%
Seminars in Cancer Biology
1 publication, 2.56%
Pharmacological Research
Pharmacological Research, 1, 2.56%
Pharmacological Research
1 publication, 2.56%
ACS Applied Nano Materials
ACS Applied Nano Materials, 1, 2.56%
ACS Applied Nano Materials
1 publication, 2.56%
Expert Opinion on Drug Delivery
Expert Opinion on Drug Delivery, 1, 2.56%
Expert Opinion on Drug Delivery
1 publication, 2.56%
Journal of Environmental and Public Health
Journal of Environmental and Public Health, 1, 2.56%
Journal of Environmental and Public Health
1 publication, 2.56%
Chemical Reviews
Chemical Reviews, 1, 2.56%
Chemical Reviews
1 publication, 2.56%
npj Computational Materials
npj Computational Materials, 1, 2.56%
npj Computational Materials
1 publication, 2.56%
Molecular Pharmaceutics
Molecular Pharmaceutics, 1, 2.56%
Molecular Pharmaceutics
1 publication, 2.56%
MedComm
MedComm, 1, 2.56%
MedComm
1 publication, 2.56%
Signal Transduction and Targeted Therapy
Signal Transduction and Targeted Therapy, 1, 2.56%
Signal Transduction and Targeted Therapy
1 publication, 2.56%
Journal of Pharmaceutical Sciences
Journal of Pharmaceutical Sciences, 1, 2.56%
Journal of Pharmaceutical Sciences
1 publication, 2.56%
ACS Applied Bio Materials
ACS Applied Bio Materials, 1, 2.56%
ACS Applied Bio Materials
1 publication, 2.56%
Pharmaceuticals
Pharmaceuticals, 1, 2.56%
Pharmaceuticals
1 publication, 2.56%
Journal of Pharmaceutical Investigation
Journal of Pharmaceutical Investigation, 1, 2.56%
Journal of Pharmaceutical Investigation
1 publication, 2.56%
Journal of Drug Delivery Science and Technology
Journal of Drug Delivery Science and Technology, 1, 2.56%
Journal of Drug Delivery Science and Technology
1 publication, 2.56%
Chemical Communications
Chemical Communications, 1, 2.56%
Chemical Communications
1 publication, 2.56%
Advanced Functional Materials
Advanced Functional Materials, 1, 2.56%
Advanced Functional Materials
1 publication, 2.56%
Exploration
Exploration, 1, 2.56%
Exploration
1 publication, 2.56%
Nature Reviews Bioengineering
Nature Reviews Bioengineering, 1, 2.56%
Nature Reviews Bioengineering
1 publication, 2.56%
Journal of Molecular Liquids
Journal of Molecular Liquids, 1, 2.56%
Journal of Molecular Liquids
1 publication, 2.56%
Cancer Nanotechnology
Cancer Nanotechnology, 1, 2.56%
Cancer Nanotechnology
1 publication, 2.56%
Smart Medicine
Smart Medicine, 1, 2.56%
Smart Medicine
1 publication, 2.56%
1
2
3
4
5

Citations by publishers

2
4
6
8
10
Wiley
Wiley, 10, 25.64%
Wiley
10 publications, 25.64%
Elsevier
Elsevier, 10, 25.64%
Elsevier
10 publications, 25.64%
Springer Nature
Springer Nature, 6, 15.38%
Springer Nature
6 publications, 15.38%
American Chemical Society (ACS)
American Chemical Society (ACS), 5, 12.82%
American Chemical Society (ACS)
5 publications, 12.82%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 3, 7.69%
Multidisciplinary Digital Publishing Institute (MDPI)
3 publications, 7.69%
Taylor & Francis
Taylor & Francis, 1, 2.56%
Taylor & Francis
1 publication, 2.56%
Hindawi Limited
Hindawi Limited, 1, 2.56%
Hindawi Limited
1 publication, 2.56%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 1, 2.56%
Royal Society of Chemistry (RSC)
1 publication, 2.56%
2
4
6
8
10
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Serov N. Y., Vinogradov V. Artificial intelligence to bring nanomedicine to life // Advanced Drug Delivery Reviews. 2022. Vol. 184. p. 114194.
GOST all authors (up to 50) Copy
Serov N. Y., Vinogradov V. Artificial intelligence to bring nanomedicine to life // Advanced Drug Delivery Reviews. 2022. Vol. 184. p. 114194.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.addr.2022.114194
UR - https://doi.org/10.1016%2Fj.addr.2022.114194
TI - Artificial intelligence to bring nanomedicine to life
T2 - Advanced Drug Delivery Reviews
AU - Serov, Nikita Yu.
AU - Vinogradov, Vladimir
PY - 2022
DA - 2022/05/01 00:00:00
PB - Elsevier
SP - 114194
VL - 184
SN - 0169-409X
SN - 1872-8294
ER -
BibTex
Cite this
BibTex Copy
@article{2022_Serov,
author = {Nikita Yu. Serov and Vladimir Vinogradov},
title = {Artificial intelligence to bring nanomedicine to life},
journal = {Advanced Drug Delivery Reviews},
year = {2022},
volume = {184},
publisher = {Elsevier},
month = {may},
url = {https://doi.org/10.1016%2Fj.addr.2022.114194},
pages = {114194},
doi = {10.1016/j.addr.2022.114194}
}
Found error?